Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.BioLife Solutions has been granted a US patent that covers the methods and compositions for the preservation of cells, tissues or organs in an artificial environment.
Subscribe to our email newsletter
The market for preserving cells and tissue is growing rapidly and is diverging into new technology areas, one of which is vitrification, or freezing rapidly to avoid the presence of ice crystals.
The issuance of the patent provides BioLife with the latest extension of its molecular-based cryopreservation technology platform and protects BioLife’s use of cell death inhibitors (calpain inhibitors) in hypothermic preservation solutions.
“Our core preservation technologies can be a critical factor in applying this new technology and solidifying our patent position in that area gives us a commercial foothold as that market develops,” commentedB ioLife president and CEO, Dr John Baust.
“We believe BioLife holds a unique and encompassing intellectual property position in the biological processing and preservation of cells, tissues and organs and that our technology significantly improves the viability of cells and organs for longer periods of time during transportation and storage,” added Dr Baust.